X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
landiolol (221) 221
urea - analogs & derivatives (108) 108
humans (103) 103
index medicus (92) 92
male (76) 76
esmolol (71) 71
female (69) 69
anesthesiology (66) 66
aged (55) 55
atrial fibrillation (54) 54
middle aged (52) 52
heart rate - drug effects (51) 51
landiolol hydrochloride (51) 51
morpholines - administration & dosage (49) 49
urea - administration & dosage (49) 49
medicine & public health (47) 47
beta-blocker (46) 46
cardiac & cardiovascular systems (42) 42
morpholines - pharmacology (40) 40
morpholines - therapeutic use (40) 40
urea - pharmacology (40) 40
urea - therapeutic use (40) 40
blood pressure - drug effects (35) 35
tachycardia (35) 35
surgery (33) 33
acting beta-blocker (32) 32
adrenergic beta-antagonists - administration & dosage (32) 32
treatment outcome (31) 31
adult (30) 30
anesthesia (29) 29
adrenergic beta-antagonists - pharmacology (26) 26
adrenergic beta-antagonists - therapeutic use (26) 26
heart rate (24) 24
infusions, intravenous (24) 24
dose-response relationship, drug (23) 23
ono-1101 (23) 23
pharmacology & pharmacy (23) 23
hydrochloride (22) 22
prospective studies (21) 21
β-blocker (21) 21
animals (20) 20
atrial-fibrillation (19) 19
morpholines - adverse effects (19) 19
rats (19) 19
urea - adverse effects (19) 19
anti-arrhythmia agents - administration & dosage (18) 18
management (18) 18
pharmacokinetics (18) 18
prevention (18) 18
heart beat (17) 17
hemodynamics - drug effects (17) 17
mortality (17) 17
pain medicine (17) 17
tracheal intubation (17) 17
anti-arrhythmia agents - therapeutic use (16) 16
electrocardiography (16) 16
propranolol (16) 16
cardiac arrhythmia (15) 15
analysis (14) 14
atrial fibrillation - drug therapy (14) 14
atrial fibrillation - etiology (14) 14
atrial fibrillation - prevention & control (14) 14
beta-blockers (14) 14
aged, 80 and over (13) 13
blocker (13) 13
cardiac surgery (13) 13
double-blind (13) 13
efficacy (13) 13
endotracheal intubation (13) 13
retrospective studies (13) 13
double-blind method (12) 12
heart failure (12) 12
hemodynamics (12) 12
arrhythmias (11) 11
blood pressure (11) 11
cardiac-surgery (11) 11
hypertension (11) 11
intensive / critical care medicine (11) 11
morpholines - pharmacokinetics (11) 11
research (11) 11
time factors (11) 11
urea - pharmacokinetics (11) 11
adrenergic beta-antagonists - adverse effects (10) 10
bispectral index (10) 10
blood-pressure (10) 10
cardiac patients (10) 10
cardiology (10) 10
cardiovascular (10) 10
complications and side effects (10) 10
coronary artery bypass (10) 10
electroconvulsive therapy (10) 10
emergency medicine (10) 10
heart (10) 10
incidence (10) 10
intubation, intratracheal (10) 10
ischemia (10) 10
medicine, research & experimental (10) 10
pharmacology (10) 10
propofol (10) 10
supraventricular tachyarrhythmias (10) 10
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (254) 254
Japanese (23) 23
Chinese (2) 2
German (2) 2
Dutch (1) 1
Portuguese (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Japanese Journal of Anesthesiology, ISSN 0021-4892, 12/2016, Volume 65, Issue 12, pp. 1255 - 1257
Journal Article
Journal of Cardiothoracic and Vascular Anesthesia, ISSN 1053-0770, 08/2019, Volume 33, Issue 8, pp. 2195 - 2200
Decreasing the heart rate (HR) using landiolol, an ultra-short-acting β-blocker, is helpful for completing a meticulous distal anastomosis during on-pump or... 
Short-acting β-blocker | Landiolol | Coronary artery bypass grafting (CABG)
Journal Article
Journal Article
Japanese Journal of Anesthesiology, ISSN 0021-4892, 01/2015, Volume 64, Issue 1, pp. 95 - 97
Journal Article
Journal of Cardiology, ISSN 0914-5087, 11/2019, Volume 74, Issue 5, pp. 418 - 425
Atrial fibrillation and atrial flutter occur commonly in patients with heart failure. Ultrashort-acting β-blockers, including landiolol, can rapidly control... 
Landiolol | Beta-blockers | Atrial fibrillation | Tachyarrhythmia | Atrial flutter
Journal Article
Trials, ISSN 1745-6215, 11/2018, Volume 19, Issue 1, pp. 637 - 8
Journal Article
CIRCULATION JOURNAL, ISSN 1346-9843, 07/2019, Volume 83, Issue 7, pp. 1456 - 1462
Background: We aimed to investigate the efficacy and safety of landiolol in Japanese patients with recurrent hemodynamically unstable ventricular tachycardia... 
Ventricular arrhythmias | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | INTRAVENOUS AMIODARONE | beta-blockers | Landiolol
Journal Article
Japanese Journal of Anesthesiology, ISSN 0021-4892, 2014, Volume 63, Issue 8, pp. 898 - 900
Journal Article
European Heart Journal Supplements, ISSN 1520-765X, 01/2018, Volume 20, Issue suppl_A, pp. A19 - A24
Abstract Atrial fibrillation (AFib) is frequently associated with heart failure. Guidelines for AFib management have been recently updated and include an... 
Heart failure | TACHYARRHYTHMIAS | IMPACT | CARDIAC & CARDIOVASCULAR SYSTEMS | LEFT-VENTRICULAR DYSFUNCTION | Atrial fibrillation | Landiolol | BETA-1-SELECTIVE BLOCKER LANDIOLOL | DECOMPENSATED HEART-FAILURE | Beta-blockers | Supraventricular tachycardia | RAPID ATRIAL
Journal Article
European Heart Journal Supplements, ISSN 1520-765X, 01/2018, Volume 20, Issue suppl_A, pp. A4 - A9
Abstract Landiolol is an intravenous ultra-short acting beta-blocker which has been used in Japan for many years to prevent and/or to treat post-operative... 
CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | MANAGEMENT | EFFICACY | SAFETY | Landiolol | PREVENTION | Post-operative atrial fibrillation | ACTING BETA-BLOCKER | Cardiac surgery | HYDROCHLORIDE | LOW-DOSE LANDIOLOL | OUTCOMES
Journal Article
GERIATRICS & GERONTOLOGY INTERNATIONAL, ISSN 1444-1586, 05/2018, Volume 18, Issue 5, pp. 816 - 817
Journal Article
Journal of Cardiothoracic and Vascular Anesthesia, ISSN 1053-0770, 12/2006, Volume 20, Issue 6, pp. 793 - 795
Journal Article
European Heart Journal Supplements, ISSN 1520-765X, 01/2018, Volume 20, Issue suppl_A, pp. A15 - A18
Abstract Landiolol is an injectable ultrashort acting beta-blocker with high beta1 selectivity indicated for heart rate control of atrial fibrillation in the... 
Heart-rate control | Intensive care | Atrial fibrillation | Supraventricular arrhythmia | Landiolol | Sepsis | Beta-blockers | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | ESMOLOL | RAT MODEL | HYDROCHLORIDE | BETA-1-SELECTIVE BLOCKER LANDIOLOL | SEPTIC SHOCK | BETA-BLOCK | OUTCOMES
Journal Article
CIRCULATION CONTROL, ISSN 0389-1844, 2017, Volume 38, Issue 1, pp. 35 - 39
Propofol suppresses both the sympathetic and parasympathetic nervous systems. There have been no clinical studies examining the infusion rate-related... 
heart rate | Anesthetics | propofol | landiolol | heart
Journal Article
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, ISSN 0031-6970, 05/2018, Volume 74, Issue 5, pp. 673 - 674
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00228-017-2409-x 
SURGERY | TRACHEAL INTUBATION | LEFT-VENTRICULAR DYSFUNCTION | PERIOPERATIVE PERIOD | DOUBLE-BLIND | TACHYCARDIA | PHARMACOLOGY & PHARMACY | ESMOLOL | BETA-BLOCKERS | LANDIOLOL | ATRIAL-FIBRILLATION
Journal Article
Journal of Cardiothoracic and Vascular Anesthesia, ISSN 1053-0770, 06/2018, Volume 32, Issue 3, pp. 1415 - 1425
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.